Google
×
Investors & Media ... Syros is driven by the motivation to help patients with blood disorders that have largely eluded other targeted approaches, and we aim to ...
Syros Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update ... View Investor Relations. © 2024 Syros Pharmaceuticals, Inc.
People also ask
Get the latest insights on Syros Pharmaceuticals, Inc. Common Stock (SYRS) with press releases and corporate news to help you in your trading and investing ...
8 hours ago · The full release is available on the Investor & Media section of the Syros' website at www.syros.com. We will begin the call with prepared ...
3 days ago · SYRS. Exchange. Nasdaq. Market Cap. 131.67m. Last Price. $6.25. 52-Week Range. $2.0902 - $8.17. Stock Overview. 03/26/2024 04:00 PM EDT.
Syros Pharmaceuticals, Inc. (US:SYRS) has 87 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange ...
(SYRS). NASDAQ: SYRS · IEX Real-Time Price · USD ... SYRS. Exchange, NASDAQ. Fiscal Year, January ... Director of Corporate Communications and Investor Relations.